Type 2 Diabetes Tied to Subsequent Risk of PD

The study was funded by the National Institute for Health Research Biomedical Research Centres at Oxford and University College London Hospitals in the United Kingdom.

The researchers reported relationships with Elan/Prothena Pharmaceuticals, GE Healthcare, Britannia Pharmaceuticals, and Corticobasal Degeneration Solutions.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner